|Bid||282.48 x 800|
|Ask||282.59 x 1000|
|Day's range||280.74 - 284.65|
|52-week range||192.79 - 309.60|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||9.65|
|Earnings date||28 Oct 2021|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||29 Mar 1994|
|1y target est||334.29|
LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Avantor (AVTR) is likely to have gained during the third quarter on the back of robust performance of its end markets.
Continued strength in Abiomed's (ABMD) Impella product line is expected to have driven up Q2 sales.